Talisa Forest, MD
Retina Specialist · Aurora, CONPI 1154783447
Payments from drug & device makers
What this record shows
This record is dominated by grants: $75,000 of the $83,558 with a category attached, or 89.8%. Alcon Research LLC accounts for 89.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $77,742 and has fallen 94.5% since, to $4,248 in 2025. Among retina specialist clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $1856.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$75K
- Genentech USA, Inc.$7K
- Alcon$532
- Dutch Ophthalmic, USA$420
- Oculus Surgical Inc.$312
- Astellas Pharma US Inc$160
- plus $320 from 3 others
What the payments were for
- Consulting fees$5,7557%
- Grants$75,00090%
- Travel & lodging$2240%
- Food & beverage$2,5793%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 1 | $75,000 |
| Genentech USA, Inc. | 21 | $6,815 |
| Alcon | 7 | $532 |
| Dutch Ophthalmic, USA | 3 | $420 |
| Oculus Surgical Inc. | 3 | $312 |
| Astellas Pharma US Inc | 1 | $160 |
| Genentech, Inc. | 5 | $129 |
| Glaukos Corporation | 1 | $109 |
| AbbVie | 3 | $82 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$6,496
- EVA, combined machine$302
- TISSUEBLUE$302
- AcrySof$259
- Izervay$160
- EVA Ophthalmic Surgical System$118
- AcrySof IQ PanOptix$109
- iStent inject W$109
- KXL System$109
- Photrexa$109
How this compares
$83,558 in reported general payments places this provider in the 90th percentile of 51 retina specialist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 17 | $671 |
| Ketorolac Tromethamine | 13 | $140 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $110 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Aurora
- Lynn HassmanAurora$16K
- Zachary KoretzAurora$14K
- Ross ChodAurora$10K
- Niranjan ManoharanAurora$9K
- Amit ReddyAurora$4K
- Rachel ChenAurora$4K
- Naresh MandavaAurora$3K
- Frank SiringoAurora$3K
- Abraham HangAurora$2K
- Sean RodriguezAurora$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.